The mPIN fails to further progress to invasive cancer due to ETV4-mediated simultaneous activation of the p53-dependent senescence program, and ETV4AAA cooperates with Trp53 loss to promote the development of focally invasive prostate cancer. Here, TP53 is linked to prostate carcinoma.